Clinical Trial Update: A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating somatropin for adults with growth hormone deficiency caused by trauma or head injury has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Traumatic Brain Injury

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Pfizer | Conditions: Brain Injuries, Growth Hormone Deficiency Dwarfism | Phase 4 | Status: TERMINATED